Key result
The CB2 receptor agonist AM1241 improved cardiac function and alleviated myocardial interstitial fibrosis in mice with MI via Nrf2-mediated down-regulation of the TGF-β1/Smad3 pathway.
Population
Mice with myocardial infarction and primary cultured cardiac fibroblasts subjected to hypoxia/serum…
Design
Preclinical
Authors
Loading...
Should not yet change post-MI care; leaves open CB2 agonism as a hypothesis-generating target for human remodeling trials.
Activation of the CB2 receptor by AM1241 ameliorates myocardial fibrosis and improves cardiac function post-myocardial infarction in mice via the Nrf2/TGF-β1/Smad3 pathway.
Li et al. (2016) studied Myocardial infarction. AM1241 was evaluated on Cardiac function and myocardial interstitial fibrosis markers. The CB2 receptor agonist AM1241 improved cardiac function and alleviated myocardial interstitial fibrosis in mice with MI via Nrf2-mediated down-regulation of the TGF-β1/Smad3 pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: